TG Therapeutics:Briumvi的增长引发收购传闻 (NASDAQ:TGTX)
· seekingalpha.com
TG Therapeutics是一个主要的收购目标,得益于Briumvi的增长以及近期皮下注射制剂的风险消除。了解为何TGTX股票值得买入。
I publish my best ideas and top coverage on the Growth Stock Forum. If you're interested in finding great growth stocks, with a focus on biotech, consider signi...